explore -WSS

explore

author：Wikipedia 2025-09-28 02:27:38 - browse：1775

Nick Leschly - Bluebird Bio — Longtime Bluebird Bio CEO Nick Leschly Wendy Maeda/The Boston Globe

Some two years after splitting biotech company Bluebird Bio into two entities in a bid to “sharpen their focus” and improve operations, the spinout focused on oncology treatments announced major cost cuts and is parting ways with its chief executive.

The spinout, 2Seventy Bio, announced Tuesday that it is cutting approximately 40% of its workforce, or about 176 employees. It also plans to allocate less money to a couple of drug candidates, including one that is currently on hold with the Food and Drug Administration. The cuts extend the company’s cash runway into 2026.

The company was formed in 2021 when the team behind Bluebird Bio decided to split its drug pipeline down the middle. The company was wrestling with its gene therapy portfolio, including getting approval for a gene therapy for the blood disorder beta thalassemia in the U.S. Separately, it had a basket of cancer drug candidates and a partnership with pharma company Bristol Myers Squibb that needed attention. So, Bluebird split its operations in two, with longtime CEO Nick Leschly taking the helm at the new firm.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Hospitals need to get ahead of regulations on climate change

hotspot

WSS

'Vaccine

Change Healthcare cyberattack shows risk of industry consolidation

Why we need mandatory labeling of GMO products

Medicare Advantage isn’t working — for anyone

Should insurance cover cosmetic surgery?

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

entertainment

explore

leisure time

The high cost of giving birth even with insurance

Childhood vaccination ad campaign launches in the U.K.

ChatGPT in medicine: STAT answers readers' burning questions

Beyond aggravation: Constipation is an American epidemic

Cancer drug shortages should be causing more outrage

Bird flu makes raw milk dangerous to consume, mouse study finds

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Change Healthcare cyberattack shows risk of industry consolidation

Tori Bowie and the unacceptable rates of Black maternal death

Laying a path for careers in science

Wikipedia

The Bio Revolution is changing business and society

Pharma’s losing bet in New Jersey

Redefining sustainability for the pharmaceutical industry

Stroke rates rising, especially in working

The Bio Revolution is changing business and society

Change Healthcare cyberattack shows risk of industry consolidation

hotspot

focus

focus

leisure time